Cargando…

PB2216: VACUOLES APPEAR IN RED BLOOD CELLS TRANSFUSED TO PATIENTS WITH SICKLE CELL DISEASE-RELATED HYPOSPLENISM

Detalles Bibliográficos
Autores principales:	Dumas, L., Sissoko, A., Fricot, A., Salama, N., Joseph, L., Manceau, S., Dokmak, S., Michel, A., Maitre, B., Gachet, C., Cavazzana, M., Roussel, C., Buffet, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429200/ http://dx.doi.org/10.1097/01.HS9.0000851692.16423.82

Ejemplares similares

P-061: DE NOVO APPEARANCE OF VACUOLES IN TRANSFUSED RED BLOOD CELLS IN SICKLE CELL DISEASE PATIENTS WITH DEFECTIVE SPLENIC FUNCTION
por: L., DUMAS, et al.
Publicado: (2022)

O-11: AUTOMATED QUANTIFICATION OF POCKED RED BLOOD CELLS CORRELATES WITH SPLEEN SIZE IN SICKLE CELL DISEASE
por: A., SISSOKO, et al.
Publicado: (2022)

P1496: OPERATOR-INDEPENDENT, FLUORESCENCE-BASED QUANTIFICATION OF POCKED RED CELLS CORRELATES WITH SPLEEN SIZE AND FUNCTION IN SICKLE CELL DISEASE
por: Sissoko, A., et al.
Publicado: (2022)

Hyposplenism revealed by Plasmodium malariae infection
por: Hommel, Benjamin, et al.
Publicado: (2013)

PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE
por: Meunier, Benoit, et al.
Publicado: (2023)

Hyposplenism—A Review
por: Foster, P. N., et al.
Publicado: (1987)

2216. Pneumonia in the ICU: Epidemiology and Outcomes
por: Blaha, Michael, et al.
Publicado: (2019)

Recommended vaccinations for asplenic and hyposplenic adult patients
por: Bonanni, Paolo, et al.
Publicado: (2016)

The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism
por: Peretz, Sari, et al.
Publicado: (2022)

Pediatric endogenous Haemophilus influenzae endophthalmitis with presumed hyposplenism
por: Haruta, Masatoshi, et al.
Publicado: (2017)

2707. Complications of Babesiosis in Immunocompromised and Asplenic/Hyposplenic Patients
por: Harris, Courtney E, et al.
Publicado: (2023)

PB2224: IMPACT OF COVID-19 PANDEMIC ON PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM THE REAL WORLD ASSESSMENT SURVEY FOR SICKLE CELL DISEASE IN SAUDI (ROARS)
por: Ezzat, H., et al.
Publicado: (2022)

PB2596: OPTIMIZING PLATELET TRANSFUSION FOR CLINICAL PRACTICE. DO PLATELETS AGE MATTER FOR THERAPEUTIC PLATELETS TRANSFUSION?
por: Attallah, Samy, et al.
Publicado: (2023)

PB2287: END OF LIFE TRANSFUSIONS IN PATIENTS WITH AN ONCOLOGICAL DIAGNOSIS
por: Duque, L., et al.
Publicado: (2022)

Hyposplenism in warm autoimmune hemolytic anemia: The missing link with venous thromboembolism?
por: Jerez, Joaquín
Publicado: (2020)

PB2217: SICKLE CELL DISEASE IS A RISK FACTOR FOR THE PROGRESSION AND PROGNOSIS OF COVID-19
por: Goyal, V., et al.
Publicado: (2022)

PB2339: PROJECTED LIFETIME ECONOMIC BURDEN OF TRANSFUSION DEPENDENT BETA-THALASSEMIA IN THE UNITED STATES
por: Udeze, C., et al.
Publicado: (2022)

Persistence of Natural Killer (NK) cell lymphocytosis with hyposplenism without development of leukaemia
por: Khan, Sujoy, et al.
Publicado: (2005)

Fatal Streptococcus pneumoniae Sepsis in a Patient With Celiac Disease-Associated Hyposplenism
por: Ouseph, Madhu M., et al.
Publicado: (2016)

PB2223: COST OF ILLNESS, EPIDEMIOLOGY AND HEALTHCARE RESOURCE UTILIZATION FOR SICKLE CELL DISEASE IN THE GULF “CESGU”
por: Soliman, D., et al.
Publicado: (2022)

PB2222: THE PROTECTIVE EFFECT OF THE SPLEEN IN SICKLE CELL PATIENTS. A COMPARATIVE STUDY BETWEEN PATIENTS WITH ASPLENIA AND HYPERSPLENISM.
por: Peretz, S., et al.
Publicado: (2022)

PB2226: THE ROLE OF COMPLEMENT IN THE IMMUNE RESPONSE OF SICKLE CELL DISEASE PATIENTS AFER COVID-19 VACCINATION
por: Varelas, C., et al.
Publicado: (2022)

PB2528: THE IMPACT OF ZINC SUPPLEMENTATION ON HYPERBILIRUBINEMIA IN SICKLE CELL DISEASE
por: Al Farttoosi, Mohammed
Publicado: (2023)

PB2517: OSTEOMYELITIS IN CHILDREN WITH SICKLE CELL DISEASE: IS MRI PATHOGNOMONIC?
por: Al Lawati, Murtadha, et al.
Publicado: (2023)

PB2314: CYTOPENIAS AND BLOOD TRANSFUSION SUPPORT AFTER CAR-T THERAPY
por: Rivada, Marcos, et al.
Publicado: (2023)

Measuring Post-transfusion Recovery and Survival of Red Blood Cells: Strengths and Weaknesses of Chromium-51 Labeling and Alternative Methods
por: Roussel, Camille, et al.
Publicado: (2018)

Clinicopathological Concordance in 2216 Cases of Skin Biopsy over One Year: An Indian Experience
por: Malik, Akanksha, et al.
Publicado: (2020)

PB2597: EVALUATION OF PEDIATRIC TRANSFUSION PRACTISES IN A TERTIARY CARE HOSPITAL
por: Aydin, Tunç, et al.
Publicado: (2023)

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW
por: Kattamis, A., et al.
Publicado: (2022)

PB2215: GLOBAL EPIDEMIOLOGY OF SICKLE CELL DISEASE: A SYSTEMATIC LITERATURE REVIEW
por: Colombatti, R., et al.
Publicado: (2022)

PB2513: A RE-AUDIT OF PAIN MANAGEMENT IN SICKLE CELL PAIN CRISES
por: Zhou, Yuhui, et al.
Publicado: (2023)

PB2507: EFFECTS OF TSH ON HEMOGLOBIN S POLYMERIZATION, DEFORMABILITY AND ADHESION ON SICKLE CELL ERYTHROCYTES
por: Reis, Evelyn Mendonça, et al.
Publicado: (2023)

PB2219: A REAL-WORLD EXPERIENCE WITH HEALTHCARE RESOURCE UTILIZATION PATTERNS AND RELATED COSTS IN PATIENTS WITH SICKLE CELL DISEASE IN NORTH LEBANON
por: Inati, A., et al.
Publicado: (2022)

PB2600: BLOOD TRANSFUSION IN CARDIAC PATIENTS IN CONSTANTA EMERGENCY COUNTY CLINICAL HOSPITAL
por: Andreea, Iulia, et al.
Publicado: (2023)

PB2011: TRANSFUSION BURDEN IS AN IMPORTANT PROGNOSTIC FACTOR IN LOWER-RISK MYELODYSPLASTIC SYNDROME
por: Lee, Jungmin, et al.
Publicado: (2023)

PB2504: USE OF CONSUMER WEARABLES TO MONITOR AND PREDICT PAIN IN PATIENTS WITH SICKLE CELL DISEASE
por: Vuong, Caroline, et al.
Publicado: (2023)

PB2335: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICAID PATIENTS WITH SICKLE CELL DISEASE (SCD): ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
por: Aggarwal, S., et al.
Publicado: (2022)

PB2291: STATUS OF IRREGULAR ANTIBODIES IN THE COVID ERA: A NEW PRESSURE FOR THE TRANSFUSION DEPARTMENT?
por: Fernandez Leyva, H.
Publicado: (2022)

PB2032: FACTORS ASSOCIATED WITH TRANSFUSION INDEPENDENCY POST TREATMENT IN HIGH RISK MDS PATIENTS
por: Fatima, Naveena, et al.
Publicado: (2023)

PB2566: EPIDEMIOLOGICAL PROFILE AND INDICATIONS FOR IV IRON THERAPY: A TRANSFUSION SPARING ALTERNATIVE
por: Laabichi, Amine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hc5jjkc39271hosdjvltp9sgpc